MedTrace Logo

Step Down FSH Approach and Late Follicular Phase in Progesterone Level

NCT03356964 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 127

Last updated 2020-09-09

No results posted yet for this study

Summary

Step-down approach and late follicular phase progesterone level

Conditions

  • Progesterone Resistance

Interventions

DRUG

follicle stimulating hormone

Follicle stimulating hormone( will be chosen according to ovarian reserve parameters in the study group the dosage will be reduced in the control group it will remain unchanged

Sponsors & Collaborators

  • Merck Serono International SA

    collaborator INDUSTRY

  • ART Fertility Clinics LLC

    lead OTHER

Principal Investigators

  • Human Fatemi · ART Fertility Clinics LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-23
Primary Completion
2020-02-12
Completion
2020-08-31

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03356964 on ClinicalTrials.gov